Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies

Lingna Li, PhD, Wenyong Tong, PhD, Megan Lau, BS, Katherine Fells, PhD, Tong Zhu, PhD, Yingqing Sun, PhD, Ernest Kovacs, PhD, Alisher Khasanov, PhD, Zheng Yan, PhD, Dalun Deng, PhD, Ken Takeshita, MD, Gunnar F. Kaufmann, PhD, Henry Ji, PhD, Hui Li, PhD, Hong Zhang, PhD

Blood (2019) 134 (Supplement_1): 5621.

https://doi.org/10.1182/blood-2019-132062

Published: 2019

Journal Articles

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

Bin Yin, PhD, Xiaofeng Han, PhD, Huikai Miao, Min Zhang, Yanwen Zheng, Huiquan Tao, Guangsong Su, Zhengwei Mao, Haiyan Xu, Hongchao Yin, Jiang Hu, Robert Peter Gale, MD ScD, PhD, Fanqing Chen

Blood (2017) 130 (Supplement 1): 5099.

https://doi.org/10.1182/blood.V130.Suppl_1.5099.5099

Published: 2017

Journal Articles

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Tadao Ishida, MD PhD, Hiroshi Yasui, MD PhD, Kazuya Ishiguro, MD, Yuka Aoki, MD PhD, Hiroshi Ikeda, MD PhD

Blood (2016) 128 (22): 2097.

https://doi.org/10.1182/blood.V128.22.2097.2097

Published: 2016

Journal Articles

Platelet CD36 Induces ERK5 Activation through a Redox-Regulated Signaling Pathway to Promote a Prothrombotic Phenotype

Moua Yang, Jeannette M. Vasquez-Vivar, PhD, Yiliang Chen, PhD, Scott J. Cameron, PhD MD, Craig N. Morrell, DVM, PhD, Roy L. Silverstein, MD

Blood (2015) 126 (23): 1033.

https://doi.org/10.1182/blood.V126.23.1033.1033

Published: 2015

Journal Articles

Peg-PLGA-PLL Nanoparticles in Combination with Gambogic Acid for Reversing Multidrug Resistance of K562/A02 Cells to Daunorubicin

Peipei Xu, PhD, Ruju Wang, Jian Ouyang, MD, Bing Chen, MD

Blood (2015) 126 (23): 4844.

https://doi.org/10.1182/blood.V126.23.4844.4844

Published: 2015

Journal Articles

PLGA-PLL-Peg-Tf-Based Targeted Nanoparticles Drug Delivery System Enhance Antitumor Efficacy Via Intrinsic Apoptosis Pathway

Wen Bao, PhD, Ran Liu, PhD, Baoan Chen, PhD Professor, Fei Wang, MD, Haijun Zhang, PhD, Guohua Xia, Xue Wu, MD, Kun Zhao, Xiaoyu Li

Blood (2015) 126 (23): 5558.

https://doi.org/10.1182/blood.V126.23.5558.5558

Published: 2015

Journal Articles

Reduced Polyethylene Glycol-Conjugated B-Domain–Deleted Factor VIII (PEG-BDD-FVIII) Clearance: Selective Peg Steric Modulation without Affecting Potency

Eric Blasko, Lilley Leong, PhD MS, Derek S Sim, PhD, Liang Tang, PhD, Elena Ho, Jim Wu, Katalin Zsofia Kauser, PhD MD DSc, Babu Subramanyam

Blood (2014) 124 (21): 1471.

https://doi.org/10.1182/blood.V124.21.1471.1471

Published: 2014

Journal Articles

Pegylated Versus Glycopegylated G-CSFs and Their Biochemical and Physiological Properties

Afsaneh Abdolzade-Bavil, Bridget A. Cooksey, Christian Scheckermann, Andreas Lammerich, Laurie Pukac, Philip Krasney, Hermann Allgaier, Wenyan David Shen, Udo Müller, Patrick Liu, Aaron von Kerczek

Blood (2013) 122 (21): 4851.

https://doi.org/10.1182/blood.V122.21.4851.4851

Published: 2013

Journal Articles

Adenosine Signaling in Priapism and Novel Therapies

Chen Ning, Jiaming Wen, Yujin Zhang, Harinder S. Juneja, Lin Qi, Rodney E. Kellems, Yang Xia

Blood (2012) 120 (21): 1006.

https://doi.org/10.1182/blood.V120.21.1006.1006

Published: 2012

Journal Articles

YM150, An Oral Direct Factor Xa Inhibitor: Combination with Aspirin or Clopidogrel In Arteriovenous Shunt Thrombosis In Rats

Yoshiyuki Iwatsuki, PhD, Chinatsu Sakata, Yumiko Moritani

Blood (2010) 116 (21): 3318.

https://doi.org/10.1182/blood.V116.21.3318.3318

Published: 2010

Journal Articles

Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients

Gabriele Buda, M.D., PhD, Enrico Orciuolo, Sara Galimberti, Matteo Pelosini, Mario Petrini, MD

Blood (2010) 116 (21): 5033.

https://doi.org/10.1182/blood.V116.21.5033.5033

Published: 2010

Journal Articles

Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD

Blood (2009) 114 (22): 2033.

https://doi.org/10.1182/blood.V114.22.2033.2033

Published: 2009

Journal Articles

Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD

Blood (2009) 114 (22): 2034.

https://doi.org/10.1182/blood.V114.22.2034.2034

Published: 2009

Journal Articles

Long-Acting Interleukin-11 Shows Improved Activity to Increase Platelet Numbers.

Yuni Jung, PhD, Haesook Ahn, Dong-Sik Kim, DVM, Yu Ri Hwang, Seong-Hyun Ho, DVM, Sujeong Kim, PhD, Jong-Mook Kim, PhD

Blood (2009) 114 (22): 3512.

https://doi.org/10.1182/blood.V114.22.3512.3512

Published: 2009

Journal Articles

Comparison of the Antithrombotic Effectiveness of the Direct Thrombin Inhibitor, Dabigatran Etexilate, and Two Factor Xa Inhibitors in an A-V Shunt Model of Thrombosis in Rabbits.

Joanne van Ryn, PhD, Norbert Hauel, PhD, Henning Priepke, PhD, Kai Gerlach, PhD, Annette Schuler-Metz, PhD, Wolfgang Wienen, PhD

Blood (2007) 110 (11): 3154.

https://doi.org/10.1182/blood.V110.11.3154.3154

Published: 2007

Journal Articles

Characterization of PEGylated Factor VIII Molecules.

Joanne Severs, Nicole Samuels, John Teare, Amy Tollner, Lisa Regan

Blood (2006) 108 (11): 4024.

https://doi.org/10.1182/blood.V108.11.4024.4024

Published: 2006

Journal Articles

Usefulness of a New Polymer Sampling Tube for Coagulation Testing in Untreated Patients and in Patients on Traditional Anticoagulant Therapy. Results of a Multicentre Evaluation.

Pierre A. Toulon, Marie-Francoise Aillaud, Dominique Arnoux, Benedicte Delahousse, Celine Gourmel

Blood (2004) 104 (11): 3974.

https://doi.org/10.1182/blood.V104.11.3974.3974

Published: 2004

Journal Articles

Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency

HD Ochs, RH Buckley, RH Kobayashi, AL Kobayashi, RU Sorensen, SD Douglas, BL Hamilton, MS Hershfield

Blood (1992) 80 (5): 1163–1171.

https://doi.org/10.1182/blood.V80.5.1163.1163

Published: 1992

NARROW

Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Platelet CD36 Induces ERK5 Activation through a Redox-Regulated Signaling Pathway to Promote a Prothrombotic Phenotype

Peg-PLGA-PLL Nanoparticles in Combination with Gambogic Acid for Reversing Multidrug Resistance of K562/A02 Cells to Daunorubicin

PLGA-PLL-Peg-Tf-Based Targeted Nanoparticles Drug Delivery System Enhance Antitumor Efficacy Via Intrinsic Apoptosis Pathway

Reduced Polyethylene Glycol-Conjugated B-Domain–Deleted Factor VIII (PEG-BDD-FVIII) Clearance: Selective Peg Steric Modulation without Affecting Potency

Pegylated Versus Glycopegylated G-CSFs and Their Biochemical and Physiological Properties

Adenosine Signaling in Priapism and Novel Therapies

YM150, An Oral Direct Factor Xa Inhibitor: Combination with Aspirin or Clopidogrel In Arteriovenous Shunt Thrombosis In Rats

Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients

Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Long-Acting Interleukin-11 Shows Improved Activity to Increase Platelet Numbers.

Comparison of the Antithrombotic Effectiveness of the Direct Thrombin Inhibitor, Dabigatran Etexilate, and Two Factor Xa Inhibitors in an A-V Shunt Model of Thrombosis in Rabbits.

Characterization of PEGylated Factor VIII Molecules.

Usefulness of a New Polymer Sampling Tube for Coagulation Testing in Untreated Patients and in Patients on Traditional Anticoagulant Therapy. Results of a Multicentre Evaluation.

Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only